Market Overview

Cellular Biomedicine Group (OTC: CBMG)

19.41 +5.14 (36.02%)

Analyst Ratings

DateResearch FirmActionCurrentPT
7/13/20BairdUpgradesOutperform28.0
3/05/20BTIG ResearchDowngradesNeutral
11/12/19BairdDowngradesNeutral19.0
9/17/19BTIGInitiates Coverage OnBuy19.0
6/25/19Cantor FitzgeraldInitiates Coverage OnOverweight27.0
2/07/19BairdInitiates Coverage OnOutperform26.0
10/03/18B. Riley FBRMaintainsBuy38.0
6/15/18Maxim GroupTerminatesHold
9/22/16Maxim GroupInitiates Coverage onBuy

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter